Page 9 - South Korean (KOSPI) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Nov 27, 2024

Explore the South Korean (KOSPI) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

255 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A377740

BioNote
₩4,725.000.7%12.8%₩478.6bn/aPE11.9xn/a4.2%

A011000

GeneOne Life Science
₩2,240.002.1%-23.4%₩175.2bn/aPS4.7xn/an/a

A102460

REYON Pharmaceutical
₩14,330.001.6%-3.6%₩258.6bn/aPE426.8xn/a1.0%

A140610

Ensol Biosciences
₩12,590.003.4%27.4%₩132.7bn/an/an/an/a

A378800

Shaperon
₩3,870.004.0%14.8%₩112.1bn/aPS1278.6xn/an/a

A144510

GC Cell
₩25,800.001.2%-18.0%₩387.7bn/aPS2.1xn/a0.4%

A373110

Xcell Therapeutics
₩5,000.009.4%n/a₩49.9bn/aPS28.1xn/an/a

A215600

SillaJen
₩3,225.001.1%-50.1%₩438.2bn/aPS360.3xn/an/a

A115450

HLB TherapeuticsLtd
₩11,240.000.6%206.1%₩897.0bn/aPS14.9xn/an/a

A092040

Amicogen
₩3,875.002.8%-38.2%₩206.7bn/aPS1.3xn/a0%

A304840

PeopleBio
₩3,945.007.8%19.5%₩77.0bn/aPS18.6xn/an/a

A033270

Korea United Pharm
₩19,270.002.2%-20.4%₩277.5bn/an/an/a2.2%

A174900

AbClon
₩14,510.002.5%20.2%₩246.7bn/aPS105.4xn/an/a

A001360

SAMSUNG PHARM
₩1,586.004.4%-31.6%₩143.0bn/an/an/an/a

A293780

AptaBio Therapeutics
₩6,730.003.9%-16.1%₩174.2bn/aPS62.3xn/an/a

A203690

Ark Solutions
₩5,170.0011.2%-51.6%₩61.2bn/aPS2.1xn/an/a

A950160

Kolon TissueGene
₩16,780.000.5%89.6%₩1.3tn/an/an/an/a

A206650

EuBiologics
₩12,880.001.8%43.9%₩462.2b₩15,000.00PS6.8xE66.3%n/a

A115180

Qurient
₩4,860.005.3%45.2%₩163.7bn/aPS19.7xn/an/a

A397030

AprilBioLtd
₩16,830.002.6%43.2%₩359.4b₩33,000.00n/an/an/a

A084650

LabGenomics
₩2,765.004.9%-32.1%₩195.6b₩5,000.00PS2.4xS39.1%0%

A084110

Huons Global
₩30,350.002.7%40.5%₩360.9bn/aPE10.2xn/a1.8%

A228760

Genomictree
₩13,680.003.1%-18.0%₩318.2bn/aPS161xE107.8%n/a

A461030

IMB Dx
₩12,430.006.1%n/a₩164.3bn/an/an/an/a
Page 9 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.